Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation-Reference-Cited by-同舟云学术

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

Published:2005-06 Issue:9475 Volume:365 Page:1934-1941
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Peggs Karl S,Hunter Ann,Chopra Rajesh,Parker Anne,Mahendra Premini,Milligan Donald,Craddock Charles,Pettengell Ruth,Dogan Ahmet,Thomson Kirsty J,Morris Emma C,Hale Geoff,Waldmann Herman,Goldstone Anthony H,Linch David C,Mackinnon Stephen

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Autologous haemopoietic cell transplantation in Hodgkin's disease;Johnston;Biol Blood Marrow Transplant,2000

2. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial;Schmitz;Lancet,2002

3. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma

4. Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group;Josting;Blood,2000

5. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients;Kolb;Blood,1990

Cited by 255 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Cell Transplantation for Hodgkin Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience;Leukemia & Lymphoma;2023-08-10

3. Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances;International Journal of Molecular Sciences;2023-06-13

4. Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents;Cancer Medicine;2023-01-18

5. Allogeneic stem cell transplant in relapsed/ refractory Hodgkin lymphoma: A 21 years’ experience;Porto Biomedical Journal;2022-09